Abstract
Glucose is a crucial molecule in energy production and produces different end products in non-tumourigenic- and tumourigenic tissue metabolism. Tumourigenic cells oxidise glucose by fermentation and generate lactate and adenosine triphosphate even in the presence of oxygen (Warburg effect). The Na+/H+-antiporter is upregulated in tumourigenic cells resulting in release of lactate- and H+ ions into the extracellular space. Accumulation of lactate- and proton ions in the extracellular space results in an acidic environment that promotes invasion and metastasis. Otto Warburg reported that tumourigenic cells have defective mitochondria that produce less energy. However, decades later it became evident that these mitochondria have adapted with alterations in mitochondrial content, structure, function and activity. Mitochondrial biogenesis and mitophagy regulate the formation of new mitochondria and degradation of defective mitochondria in order to combat accumulation of mutagenic mitochondrial deoxyribonucleic acid. Tumourigenic cells also produce increase reactive oxygen species (ROS) resulting from upregulated glycolysis leading to pathogenesis including cancer. Moderate ROS levels exert proliferative- and prosurvival signaling, while high ROS quantities induce cell death. Understanding the crosstalk between aberrant metabolism, redox regulation, mitochondrial adaptions and pH regulation provides scientific- and medical communities with new opportunities to explore cancer therapies.
Similar content being viewed by others
References
Amith SR, Fliegel L (2017) Na+/H+ exchanger-mediated hydrogen ion extrusion as a carcinogenic signal in triple-negative breast cancer etiopathogenesis and prospects for its inhibition in therapeutics. Semin Cancer Biol 46:35–41
Aquino-Gálvez A, González-Ávila G, Delgado-Tello J, Castillejos-López M, Mendoza-Milla C, Zúñiga J, Checa M, Maldonado-Martínez HA, Trinidad-López A, Cisneros J, Torres-Espíndola LM, Hernández-Jiménez C, Sommer B, Cabello-Gutiérrez C, Gutiérrez-González LH (2016) Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia. Oncol Rep 35:577–583
Barteczek P, Li L, Ernst A-S, Böhler L-I, Marti HH, Kunze R (2016) Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke. J Cereb Blood Flow Metab 37:291–306
Bellance N, Benard G, Furt F, Begueret H, Smolkova K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566–2577
Bhandari V, Hoey C, Liu LY, Lalonde E, Ray J, Livingstone J, Lesurf R, Shiah YJ, Vujcic T, Huang X, Espiritu SMG, Heisler LE, Yousif F, Huang V, Yamaguchi TN, Yao CQ, Sabelnykova VY, Fraser M, Chua MLK, van der Kwast T, Liu SK, Boutros PC, Bristow RG (2019) Molecular landmarks of tumor hypoxia across cancer types. Nat Genet 541:308–318
Böhme I, Bosserhoff AK (2016) Acidic tumor microenvironment in human melanoma. Pigment Cell Melanoma Res 29:508–523
Boland ML, Chourasia AH, Macleod KF (2013) Mitochondrial dysfunction in cancer. Front Oncol. https://doi.org/10.3389/fonc.2013.00292
Cazzaniga M, Bonanni B (2015) Relationship between metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical implications. Anticancer Res 35:5789–5796
Chaabane W, User SD, El-Gazzah M, Jaksik R, Sajjadi E, Rzeszowska-Wolny J, Los MJ (2013) Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch Immunol Ther Exp 61:43–58
Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouysségur J (2009) Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 69:358–368
Chourasia AH, Boland ML, Macleod KF (2015) Mitophagy and cancer. Cancer Metab. https://doi.org/10.1186/s40170-015-0130-8
Christie CF, Fang D, Hunt EG, Morris ME, Rovini A, Heslop KA, Beeson GC, Beeson CC, Maldonado EN (2019) Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content. FASEB J 33:8186–8201
Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, Cline GW, Phillips AJ (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513:559–563
Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK, O’Brien JP, Pierce KA, Gui DY, Sullivan LB, Wasylenko TM, Subbaraj L, Chin CR, Stephanopolous G, Mott BT, Jacks T, Clish CB, Vander Heiden MG (2016) Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer. Cell Metab 23:517–528
De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F (2015) Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells. Oncotarget 6:14777–14795
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20
Derouet MF, Dakpo E, Wu L, Zehong G, Conner J, Keshavjee S, de Perrot M, Waddell T, Elimova E, Yeung J, Darling GE (2018) miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression. Oncotarget 9:15198–15207
Desai S, Ding M, Wang B, Lu Z, Zhao Q, Shaw K, Yung WK, Weinstein JN, Tan M, Yao J (2014) Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. Oncotarget 5:8202–8210
Drake LE, Springer MZ, Poole LP, Kim CJ, Macleod KF (2017) Expanding perspectives on the significance of mitophagy in cancer. Semin Cancer Biol 47:110–124
El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Visvakarma N, Ibrahim-Hashim Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffel B, Gillies R (2018) Acidity promotes tumor progression by altering macrophage phenotype in prostate cancer. BioRxiv. https://doi.org/10.1101/478420
Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73:1524–1535
Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, Jain RK (2001) Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61:6020–6024
Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447–464
Garrett SM, Whitaker RM, Beeson CC, Schnellmann RG (2014) Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury. J Pharmacol Exp Ther 350:257–264
Garrido-Maraver J, Paz MV, Cordero MD, Bautista-Lorite J, Oropesa-Avila M, de la Mata M, Pavón AD, de Lavera I, Alcocer-Gómez E, Galán F, Ybot González P, Cotán D, Jackson S, Sánchez-Alcázar JA (2015) Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease. Biochim Biophys Acta 1852:2535–2553
Gentric G, Kieffer Y, Mieulet V, Goundiam O, Bonneau C, Nemati F, Hurbain I, Raposo G, Popova T, Stern MH, Lallemand-Breitenbach V, Müller S, Cañeque T, Rodriguez R, Vincent-Salomon A, de Thé H, Rossignol R, Mechta-Grigoriou F (2019) PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers. Cell Metab 29:156–173
Glasauer A, Chandel NS (2014) Targeting antioxidants for cancer therapy. Biochem Pharmacol 92:90–101
Gonzalez-Mendendez P, Hevia D, Alonso-Arias R, Alvarez-Artime A, Rodriquez-Garcia A, Gonzalez-Pola I (2018) GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress. Redox Biol 17:112–127
Gu CJ, Xie F, Zhang B, Yang H-L, Cheng J, He YY, Zhu XY, Li DJ, Li MQ (2018) High glucose promotes epithelial–mesenchymal transition of uterus endometrial cancer cells by increasing ER/GLUT4-mediated VEGF secretion. Cell Physiol Biochem 50:706–720
Guaragnella N, Giannattasio S, Moro L (2014) Mitochondrial dysfunction in cancer chemoresistance. Biochem Pharmacol 92:62–72
Guo H, Nan Y, Zhen Y, Zhang Y, Guo L, Yu Huang Q, Zhong Y (2016) miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1. Tumor Biol 37:13751–13761
Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB (2012) Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal 16:1295–1322
Gwak H, Haegeman G, Tsang BK, Song YS (2015) Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells. Mol Carcinog 54:1529–1540
Halcrow PW, Khan N, Datta G, Ohm JE, Ohm JE, Chen X, Geiger JD (2019) Importance of measuring endolysosome, cytosolic, and extracellular pH in understanding the pathogenesis of and possible treatments for glioblastoma multiforme. Cancer Rep. https://doi.org/10.1002/cnr2.1193
Hardy K, Brand-Miller J, Brown KD, Thomas MG, Copeland L (2015) The importance of dietary carbohydrate in human evolution. Q Rev Biol 90:251–268
Hatami S, White CW, Shan S, Haromy A, Qi X, Ondrus M, Kinnear A, Himmat S, Michelakis E, Nagendran J, Freed DH (2019) Myocardial functional decline during prolonged ex situ heart perfusion. Ann Thorac Surg. https://doi.org/10.1016/j.athoracsur.2019.01.076
Hernández-Reséndiz I, Gallardo-Pérez JC, López-Macay A, Robledo-Cadena DX, García-Villa E, Gariglio P, Saavedra E, Moreno-Sánchez R, Rodríguez-Enríquez S (2019) Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells. J Cell Physiol 234:5524–5536
Hillis AL, Lau AN, Devoe CX, Dayton TL, Danai LV, Di Vizio D, Vander Heiden MG (2018) PKM2 is not required for pancreatic ductal adenocarcinoma. Cancer Metab. https://doi.org/10.1186/s40170-018-0188-1
Hirpara J, Eu JQ, Tan JKM, Wong AL, Clement MV, Kong LR, Ohi N, Tsunoda T, Qu J, Goh BC, Pervaiz S (2019) Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance. Redox Biol. https://doi.org/10.1016/j.redox.2018.101076
Hsu C-C, Lee H-C, Wei Y-H (2013) Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma. World J Gastroenterol 19:8880–8886
Huang S, Tang Y, Peng X, Cai X, Wa Q, Ren D, Li Q, Luo J, Li L, Zou X, Huang S (2016) Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs. Oncol Rep 36:2025–2032
Jeon S-M, Hay N (2015) The double-edged sword of AMPK signaling in cancer and its therapeutic implications. Arch Pharm Res 38:346–357
Jeon S-M, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485(7400):661–665
Jiang Y, Wang D, Ren H, Shi Y, Gao Y (2019) miR-145-targeted HBXIP modulates human breast cancer cell proliferation. Thoracic Cancer 10:71–77
Jin Y, Cai Q, Shenoy AK, Lim S, Zhang Y, Charles S, Tarrash M, Fu X, Kamarajugadda S, Trevino JG, Tan M, Lu J (2016) Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation. Oncotarget 7:25113
Jose C, Bellance N, Rossignol R (2011) Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma? Biochem Biophys Acta 1807:552–561
Kang Y-H, Yi M-J, Kim M-J, Park M-T, Bae S, Kang C-M, Cho CK, Park IC, Park MJ, Rhee CH, Hong SI, Chung HY, Lee YS, Lee SJ (2004) Caspase-independent cell death by arsenic trioxide in human cervical cancer cells. Cancer Res 64:8960–8967
Kasiappan R, Safe SH (2016) ROS-inducing agents for cancer chemotherapy. React Oxyg Species 1:22–37
Kasim V, Xie Y-D, Wang H-M, Huang C, Yan X-S, Nian W-Q, Zheng XD, Miyagishi M, Wu SR (2017) Transcription factor Yin Yang 2 is a novel regulator of the p53/p21 axis. Oncotarget 8:54694–54707
Kim Y, Lee YS, Kang SW, Kim S, Kim TY, Lee SH, Hwang SW, Kim J, Kim EN, Ju JS, Park YY, Kweon MN (2019) Loss of PKM2 in Lgr5+ intestinal stem cells promotes colitis-associated colorectal cancer. Sci Rep 9:6212. https://doi.org/10.1038/s41598-019-42707-8
Kryeziu K, Pirker C, Englinger B, van Schoonhoven S, Spitzwieser M, Mohr T, Körner W, Weinmüllner R, Tav K, Grillari J, Cichna-Markl M, Berger W, Heffeter P (2016) Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells. Oncotarget 7:27379–27393
LeBleu VS, O’Connell JT, Herrera KNG, Wikman-Kocher H, Pantel K, Haigis MC (2014) PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis. Nat Cell Biol 16:992–1003
Lee JH, Choi YS, Park JH, Kim H, Lee I, Won YB, Yun BH, Park JH, Seo SK, Lee BS, Cho S (2019) MiR-150-5p may contribute to pathogenesis of human leiomyoma via regulation of the Akt/p27Kip1 pathway in vitro. Int J Mol Sci. https://doi.org/10.3390/ijms20112684
Li X, Wu H, Wu M, Feng Y, Wu S, Shen X, He J, Luo X (2019) Hypoxia-related miR-210-5p and miR-210-3p regulate hypoxia-induced migration and epithelial–mesenchymal transition in hepatoma cells. Int J Clin Exp Med 12:5096–5104
Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41:211–218
Liu L, Qi L, Knifley T, Piecoro DW, Rychahou P, Liu J, Mitov MI, Martin J, Wang C, Wu J, Weiss HL, Butterfield DA, Evers BM, O’Connor KL, Chen M (2019a) S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2. J Biol Chem 294:7516–7527
Liu M, Zhang Z, Wang H, Chen X, Jin C (2019b) Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2. Int J Biol Sci 15:617–627
Liu Z, He F, OuYang S, Li Y, Ma F, Chang H, Cao D, Wu J (2019c) miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms’ tumor. BMC Cancer. https://doi.org/10.1186/s12885-019-5609-1
Lu H, Li G, Liu L, Feng L, Wang X, Jin H (2013) Regulation and function of mitophagy in development and cancer. Autophagy 9:1720–1736
Lu C-L, Qin L, Liu H-C, Candas D, Fan M, Li JJ (2015a) Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition—a Warburg-reversing effect. PLoS ONE 10:e0121046
Lu J, Tan M, Cai Q (2015b) The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett 356:156–164
Lunetti P, Di Giacomo M, Vergara D, De Domenico S, Maffia M, Zara V, Capobianco L, Ferramosca A (2019) Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes. FASEB J 286:688–709
Morita M, Sato T, Nomura M, Sakamoto Y, Inoue Y, Tanaka R, Ito S, Kurosawa K, Yamaguchi K, Sugiura Y, Takizaki H, Yamashita Y, Katakura R, Sato I, Kawai M, Okada Y, Watanabe H, Kondoh G, Matsumoto S, Kishimoto A, Obata M, Matsumoto M, Fukuhara T, Motohashi H, Suematsu M, Komatsu M, Nakayama KI, Watanabe T, Soga T, Shima H, Maemondo M, Tanuma N (2018) PKM1 confers metabolic advantages and promotes cell-autonomous tumor cell growth. Cancer Cell 33:355–367
Nie ZY, Liu XJ, Zhan Y, Liu MH, Zhang XY, Li ZY, Lu YQ, Luo JM, Yang L (2019) miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1. Biosci Rep. https://doi.org/10.1042/BSR20190150
Palikaras K, Tavernarakis N (2014) Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol 56:182–188
Palikaras K, Lionaki E, Tavernarakis N (2016) Mitophagy: in sickness and in health. Mol Cell Oncol. https://doi.org/10.1080/23723556.2015.1056332
Pelicano H, Martin D, Xu R, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633–4646
Peppicelli S, Andreucci E, Ruzzolini J, Laurenzana A, Margheri F, Fibbi G, Del Rosso M, Bianchini F, Calorini L (2017) The acidic microenvironment as a possible niche of dormant tumor cells. Cell Mol Life Sci 74:2761–2771
Prasad A, Khudaynazar N, Tantravahi RV, Gillum AM, Hoffman BS (2016) ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines. Oncotarget 7:79388–79400
Rademaker G, Costanza B, Anania S, Agirman F, Maloujahmoum N, Di Valentin E, Goval JJ, Bellahcène A, Castronovo V, Peulen O (2019) Myoferlin contributes to the metastatic phenotype of pancreatic cancer cells by enhancing their migratory capacity through the control of oxidative phosphorylation. Cancers. https://doi.org/10.3390/cancers11060853
Schmidt M, Voelker H-U, Kapp M, Krockenberger M, Dietl J, Kammerer U (2010) Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J Cancer Res Clin Oncol 136:219–225
Scott TL, Rangaswamy S, Wicker CA, Izumi T (2014) Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair. Antioxid Redox Signal 20:708–726
Sheng B, Wang X, Su B, Hg Lee, Casadesus G, Perry G, Zhu X (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. J Neurochem 120:419–429
Siebeneicher H, Bauser M, Buchmann B, Heisler I, Mueller T, Neuhaus R, Rehwinkel H, Telser J, Zorn L (2016) Identification of novel GLUT inhibitors. Bioorg Med Chem Lett 26:1732–1737
Stubbs M, McSheehy PM, Griffiths JR, Bashford CL (2000) Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6:15–19
Sudhagar S, Sathya S, Gokulapriya G, Lakshmi B (2016) AKT-p53 axis protect cancer cells from autophagic cell death during nutrition deprivation. Biochem Biophys Res Commun 471:396–401
Sui G, Affar EB, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, Shi Y (2004) Yin Yang 1 is a negative regulator of p53. Cell 117:859–872
Sullivan LB, Chandel NS (2014) Mitochondrial reactive oxygen species and cancer. Cancer Metab. https://doi.org/10.1186/2049-3002-2-17
Szablewski L (2013) Expression of glucose transporters in cancers. Cancer 1835:164–169
Tang D, Gao J, Wang S, Ye N, Chong Y, Huang Y, Wang J, Li B, Yin W, Wang D (2016) Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression. Tumor Biol 37:1889
Tataranni T, Fi Agriest, Pacelli C, Ruggieri V, Laurenzana I, Mazzoccoli C, Sala GD, Panebianco C, Pazienza C, Capitanio V, Piccoli C (2019) Dichloroacetate affects mitochondrial function and stemness-associated properties in pancreatic cancer cell lines. Cell. https://doi.org/10.3390/cells8050478
Thiessen SE, Vanhorebeek I, Derese I, Gunst J, Van den Berghe G (2015) FGF21 response to critical illness: effect of blood glucose control and relation with cellular stress and survival. J Clin Endocrinol Metab 100:E1319–E1327
Viale A, Corti D, Draetta GF (2015) Tumors and mitochondrial respiration: a neglected connection. Cancer Res 75:3687–3691
Vyas S, Zaganjor E, Haigis MC (2016) Mitochondria and cancer. Cell 166:555–566
Wang X, Moraes CT (2011) Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels. Mol Oncol 5:399–409
Wang Y, Wu S, Huang C, Li Y, Zhao H, Kasim V (2018) Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3. Cancer Sci 109:2423
Wang Y, Shu Y, Gu C, Fan Y (2019) The novel sugar transport, SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer. Cancer Manag Res 11:865–976
Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530
Whitaker RM, Wills LP, Stallons LJ, Schnellmann RG (2013) cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury. J Pharmacol Exp Ther 347:626–634
Whitworth AJ, Pallanck LJ (2017) PINK1/Parkin mitophagy and neurodegeneration—what do we really know in vivo? Curr Opin Genet Dev 44:47–53
Wieman HL, Wofford JA, Rathmell JC (2007) Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 18:1437–1446
Wojtkowiak JW, Rothberg JM, Kumar V, Schramm KJ, Haller E, Proemsey JB, Lloyd MC, Sloane BF, Gillies RJ (2012) Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72:3938–3947
Wong J, Choi SYC, Liu R, Xu E, Killam J, Gout PW, Wang Y (2019) Potential therapies for infectious diseases based on targeting immune evasion mechanisms that pathogens have in common with cancer cells. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2019.00025
Wu S, Kasim V, Kano MR, Tanaka S, Ohba S, Miura Y, Liu X, Matsuhashi A, Chung UI, Yang L, Kataoka K, Nishiyama N, Miyagishi M (2013) Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner. Cancer Res 73(6):1787–1799
Xiong H, Chen S, Lai L, Yang H, Xu Y, Pang J, Su Z, Lin H, Zheng Y (2019) Modulation of miR-34a/SIRT1 signaling protects cochlear hair cells against oxidative stress and delays age-related hearing loss through coordinated regulation of mitophagy and mitochondrial biogenesis. Neurobiol Aging 79:30–42
Xu L, Fukumura D, Jain RK (2002) Acidic extracellular ph induces vascular endothelial growth factor (vegf) in human glioblastoma cells via erk1/2 mapk signaling pathway mechanism of low pH-induced VEGF. J Biol Chem 277:11368–11374
Xu S, Zhu X, Zhang C, Huang W, Zhou Y, Yan D (2018) Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor. Nat Commun. https://doi.org/10.1038/s41467-018-04318-1
Yang X, Zhao H, Yang J, Ma Y, Liu Z, Li Z, Li C, Wang T, Yan Z, Du N (2019a) miR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg effect. Biochem Biophys Res Commun 515(1):85–91
Yang Z, Li H, Wang W, Zhang J, Jia S, Wang J, Wei J, Lei D, Hu K, Yang X (2019b) CCL2/CCR99 axis promotes the progression of salivary adenoid cystic carcinoma via recruiting and reprogramming the tumor-associated macrophages. Front Oncol. https://doi.org/10.3389/fonc.2019.00231
Yao C, Wang W, Wang P, Zhao M, Li X, Zhang F (2018) Near-infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-/H2O2-responsive O2-evolving synergetic cancer activity. Adv Mater. https://doi.org/10.1002/adma.201704833
Yao A, Xiang Y, Si YR, Fan LJ, Li JP, Li H, Guo W, He HX, Liang XJ, Tan Y, Bao LY, Liao XH (2019a) PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells. J Cell Biochem 120:6542–6554
Yao C-H, Wang R, Wang Y, Kung CP, Weber JD, Patti GJ (2019b) Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation. Elife. https://doi.org/10.7554/eLife.41351
Ye G, Qin Y, Wang S, Pan D, Xu S, Wu C, Wang X, Wang J, Ye H, Shen H (2019) Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway. Cancer Biol Ther 20:711–719
Yokoyama M, Tanuma N, Shibuya R, Shiroki T, Abue M, Yamamoto K, Miura K, Yamaguchi K, Sato I, Tamai K, Satoh K (2018) Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. J Oncol 52:881–891
Zhang S, Pei M, Li Z, Li H, Liu Y, Li J (2018) Double-negative feedback interaction between DNA methyltransferase 3A and miRNA-145 in the Warburg effect of ovarian cancer cells. Cancer Sci 109:2734–2745
Zhao Y, Zhang L, Wu Y, Dai Q, Zhou Y, Li Z, Yang L, Guo Q, Lu N (2018) Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53. Pharmacol Res 135:49–59
Zhao R, Li L, Yang J, Niu Q, Wang H, Qin X, Zhu N, Shi A (2019) Overexpression of pyruvate kinase M2 in tumor tissues is associated with poor prognosis in patients with hepatocellular carcinoma. Pathol Oncol Res. https://doi.org/10.1007/s12253-019-00630-3
Zhu J, Wang KZ, Chu CT (2013) After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy 9:1663–1676
Zong W-X, Rabinowitz JD, White E (2016) Mitochondria and cancer. Mol Cell 61:667–676
Acknowledgements
Funds were provided by Prof. AM Joubert who acquired grants from the National Research Foundation (Grant Nos. N00591, N00375, N00903, N01716), the Cancer Association of South Africa (Grant Nos. AOV741, AOW228), the Struwig Germeshuysen Trust, the School of Medicine Research Committee of the University of Pretoria and Medical Research Council of South Africa. Additional funding was provided by Dr. MH Visagie whom received grants from the National Research Foundation, the School of Medicine Research Committee of the University of Pretoria and Struwig Germeshysen Trust. A special acknowledgement to Dr. TV Mqoco who assisted with subsidies obtained from Thutukha National Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lebelo, M.T., Joubert, A.M. & Visagie, M.H. Warburg effect and its role in tumourigenesis. Arch. Pharm. Res. 42, 833–847 (2019). https://doi.org/10.1007/s12272-019-01185-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-019-01185-2